Description
Description
Oxandrolone is an oral anabolic steroid. It goes under different names such as Anavar, Oxandrin, Var and Oxanabol. We offer oxandrolone la pharma in 10mg and 5mg tablets, so it is up to you which one you prefer more. It is categorized as a C17-alpha alkylated steroid, a derivative of DHT (dihydrotestosterone). This is considered one of the mildest anabolic steroids on the market.
It anabolic ratio is 3x times stronger than testosterone and androgecic is the lowest among all steroids – 320:24. In USA it is listed under Schedule III controlled substances. People also call Oxandrolone a girly steroid. It is one of the rare steroids that women can use. Most anabolic steroids are too strong for them.
Anavar is used as a cutting supplement in men and as both cutting and bulking supplement in women. Men have to stack it with other bulking steroids such as Testosterone Enanthate and Dianabol to achieve muscle and weight gain. Oxandrolone is great for reducing hard reach fat in the area around stomach, upper legs and lower back.
Some of Oxandrolone benefits:
Increased protein synthesis, energy boost, lean muscle mass, fat loss, strength increase, nitrogen retention, doesn’t convert to estrogen… By the end of your cycle you will have more defined physique with incredible strength. Since it doesn’t convert to estrogen you will avoid estrogenic side effects such as water retention and gynecomastia. Dosage of Oxandrolone depends whether you are an athlete or bodybuilding.
Athletes take significantly lower doses than bodybuilders, for them 30mg a day is more than enough. This is also valid for beginner steroid users. More advance users increase their daily dosages to 50-80mg. You can increase up to 100mg but be careful. Women take 10-15mg and competitive female bodybuilders take 20mg a day. Oxandrolone doesn’t cause stress on the liver as other oral anabolic steroids.
This means that you can take it for longer period. The length of cycle for men is 8 week and 4 weeks for women.
Reviews
There are no reviews yet.